Blood test may spare Head-Injury patients on blood thinners from unnecessary CT scans
NCT ID NCT03780062
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether measuring S100B protein levels in the blood can safely rule out serious brain injuries in adults with minor head trauma who take antiplatelet drugs (blood thinners). 720 participants had a blood test upon arriving at the emergency room, followed by a CT scan 4-8 hours later. The goal was to see if a low S100B level could reliably predict no need for surgery or hospitalisation, potentially avoiding CT scans and radiation exposure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- S100B protein blood test
- What this could lead to
- If successful, this blood test could help doctors quickly rule out dangerous brain injuries in patients on blood thinners after a minor head bump, reducing the need for CT scans.
- What could go wrong
- This is a completed Phase 3 trial, but the test may not be accurate enough in all patients, and false negatives could miss serious injuries. Results need validation in broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
720 people
The number who actually took part.
- Started
-
Jan 2019
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \> 18 Years old * Minor traumatic brain injury measured by a Glasgow score between 13 and 15 * Antiplatelet agent therapy * Free subject without tutorship or curatorship Exclusion Criteria: * Age \< 18 years old * Glasgow score \<13 * Traumatic brain injury older than 6 hours * Patient without any social security system * Patient with renforced protection (tutorship, curatorship, …)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Minor traumatic brain injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU of MONTPELLIER
Montpellier, 34090, France
-
CHU of NICE
Nice, 06003, France
-
CHU of POITIERS
Poitiers, 86021, France
-
La Pité Salpêtrière
Paris, 75013, France